VLNS — The Valens Company Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Company fundamentals

MetricCached value
Price (USD)0.76
Market cap (USD)61,458,912
P/E-0.88
ROE (%)-25.35
Net profit margin (%)-62.72
Revenue growth (%)Not available
Dividend yield (%)0

Price last refreshed: .

Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.

About The Valens Company Inc.

Available company fundamentals for VLNS in Drug Manufacturers - Specialty & Generic. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.